We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Study Recommends Using MRI Screening for Pancreatic Cancer in High-Risk Patients

By MedImaging International staff writers
Posted on 14 Apr 2015
Print article
Image: MRI Image of a Pancreatic Tumor and Intraoperative Sutus (Photo courtesy of JAMA Surgery).
Image: MRI Image of a Pancreatic Tumor and Intraoperative Sutus (Photo courtesy of JAMA Surgery).
Results of a study that investigated the effectiveness of Magnetic Resonance Imaging for screening high-risk individuals for pancreatic cancer have been published online in the journal JAMA Surgery, on April 8, 2015.

The study was carried out by researchers at the Karolinska Institute (Stockholm, Sweden) and was intended to find a suitable modality for clinical surveillance of individuals with a genetic risk for developing pancreatic cancer. Current screening methods include MRI, Computed Tomography (CT), endoscopic ultrasound, and endoscopic retrograde cholangiopancreatography.

The researchers used an MRI-based surveillance program to study high-risk patients referred to Karolinska University Hospital (Solna, Stockholm, Sweden) between January 1, 2010, and January 31, 2013. The researchers studied 40 patients (16 men, and 24 women) with a mean age of 49.9 years, and a mean length of follow-up of 12.9 months.

The results of the study showed that by using a noninvasive MRI-based screening protocol the researchers were able to detect pancreatic lesions in 40% of the patients. Five of the patients underwent surgery.

Related Links:

Karolinska Institute
Karolinska University Hospital


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Oncology Information System
RayCare
Dose Calibration Electrometer
PC Electrometer
New
Ultrasound System
Acclarix AX9

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.